- Home
- PLAY vs AQST Comparison
PLAY vs AQST Comparison
Compare PLAY & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLAY | AQST |
|---|---|---|
| Founded | 1982 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 484.5M | 504.0M |
| IPO Year | 2011 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PLAY | AQST |
|---|---|---|
| Price | $12.33 | $4.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $23.83 | $9.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.2M |
| Earning Date | 06-09-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $67,430,000.00 |
| Revenue This Year | $5.57 | $10.08 |
| Revenue Next Year | $5.00 | $49.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $9.61 | $2.22 |
| 52 Week High | $35.38 | $7.55 |
Technical Indicators
Market Signals| Indicator | PLAY | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 44.18 | 45.90 |
| Support Level | $9.61 | $3.70 |
| Resistance Level | $15.29 | $4.32 |
| Average True Range (ATR) | 0.85 | 0.15 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 14.58 | 22.09 |
Price Performance
Historical ComparisonAbout PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.